Lacutamab (Anti-KIR3DL2 / CD158k), 1mg*25

Lacutamab (Anti-KIR3DL2 / CD158k), 1mg*25

Lirilumab (Anti-KIR), 1mg*5

Lirilumab (Anti-KIR), 1mg*5

Lirilumab (Anti-KIR), 1mg

2.614,43 RON
SKU
SKM_A2419_1mg

Lirilumab (Anti-KIR) is a  fully human monoclonal antibody against killer-cell immunoglobulin-like receptors (KIR), with potential antineoplastic activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research. MW: 150 kD.

Mai multe informatii
Price 2.197,00 RON (preturile sunt fara TVA)
Description

Lirilumab (Anti-KIR) is a  fully human monoclonal antibody against killer-cell immunoglobulin-like receptors (KIR), with potential antineoplastic activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research. MW: 150 kD.